Investigation of Factors Considered by Health Technology Assessment Agencies in Eight Countries.
Akira YuasaNaohiro YonemotoSven DemiyaChihiro FoellscherShunya IkedaPublished in: PharmacoEconomics - open (2020)
Although clinical factors play a predominant role in the decision to reimburse medicine, HTA organizations consider additional aspects as well. If the methodology of HTA was clearly outlined, there would be more transparency in HTA systems leading to better understanding amongst stakeholders about decision making.